Hepatitis C and diabetes: the inevitable coincidence? (Q37432092)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

review article

1 reference

title

Hepatitis C and diabetes: the inevitable coincidence? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Salvatore Petta

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Antonio Craxì

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2

Luigi Elio Adinolfi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Paola Loria

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

25 January 2020

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

293-308

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

[The pathogenesis of hepatogenic diabetes mellitus].

25 January 2020

cites work

1 reference

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

21 January 2018

1 reference

Hepatitis C and steatosis: a reappraisal

21 January 2018

1 reference

Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease

21 January 2018

1 reference

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

Hepatic steatosis and insulin resistance: does etiology make a difference?

21 January 2018

1 reference

Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice

21 January 2018

1 reference

The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans

21 January 2018

1 reference

Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Fibrogenic impact of high serum glucose in chronic hepatitis C.

21 January 2018

1 reference

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

21 January 2018

1 reference

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

21 January 2018

1 reference

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

21 January 2018

1 reference

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

21 January 2018

1 reference

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

21 January 2018

1 reference

Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients

21 January 2018

1 reference

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients

21 January 2018

1 reference

Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study

21 January 2018

1 reference

Hepatitis C virus infection and incident type 2 diabetes

21 January 2018

1 reference

High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury

21 January 2018

1 reference

Hepatitis C virus infection: molecular pathways to metabolic syndrome

21 January 2018

1 reference

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway

21 January 2018

1 reference

A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals

21 January 2018

1 reference

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

21 January 2018

1 reference

Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.

21 January 2018

1 reference

TNF-{alpha}, chronic hepatitis C and diabetes: a novel triad

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

Involvement of the PA28 -Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein

21 January 2018

1 reference

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

21 January 2018

1 reference

Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt/protein kinase B signaling pathway for insulin resistance

21 January 2018

1 reference

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.

21 January 2018

1 reference

Association of diabetes mellitus and chronic hepatitis C virus infection.

21 January 2018

1 reference

Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients

21 January 2018

1 reference

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

21 January 2018

1 reference

Serum adiponectin in chronic hepatitis C and B.

21 January 2018

1 reference

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

21 January 2018

1 reference

Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines

21 January 2018

1 reference

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

21 January 2018

1 reference

Community-based seroepidemiological survey of HCV infection in Catalonia, Spain

21 January 2018

1 reference

Seroprevalence, viremia and genotype distribution of hepatitis C virus: a community-based population study in northern Italy

21 January 2018

1 reference

The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.

21 January 2018

1 reference

Endemic hepatitis C virus infection in a Sicilian town: further evidence for iatrogenic transmission

21 January 2018

1 reference

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.

21 January 2018

1 reference

Incident hepatitis C virus infection in a community-based population in Japan

21 January 2018

1 reference

Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence

21 January 2018

1 reference

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002.

21 January 2018

1 reference

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

21 January 2018

1 reference

Prevalence of the metabolic syndrome among Italian adults according to ATP III definition.

21 January 2018

1 reference

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

21 January 2018

1 reference

Metabolic syndrome: a solution in search of a problem

21 January 2018

1 reference

The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.

21 January 2018

1 reference

Hepatitis C: a metabolic liver disease

21 January 2018

1 reference

Concluding remarks: metabolic syndrome, liver and HCV.

21 January 2018

1 reference

Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.

21 January 2018

1 reference

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

Hepatitis C, metabolic syndrome, and inflammatory markers: results from the Third National Health and Nutrition Examination Survey [NHANES III].

21 January 2018

1 reference

Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection

21 January 2018

1 reference

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

21 January 2018

1 reference

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease

21 January 2018

1 reference

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.

21 January 2018

1 reference

Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study

21 January 2018

1 reference

Fatigue in patients with chronic hepatitis C.

21 January 2018

1 reference

The hepatitis C virus-associated dysmetabolic syndrome.

21 January 2018

1 reference

Dysmetabolic changes associated with HCV: a distinct syndrome?

21 January 2018

1 reference

High prevalence of hepatitis C virus infection in diabetic patients

21 January 2018

1 reference

Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus

21 January 2018

1 reference

Hepatitis C as a risk factor for diabetes type 2: lack of evidence in a hospital in central-west Brazil

21 January 2018

1 reference

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

21 January 2018

1 reference

A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan

21 January 2018

1 reference

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.

21 January 2018

1 reference

Prevalence of Type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia

21 January 2018

1 reference

Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users

21 January 2018

1 reference

Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients

21 January 2018

1 reference

Hepatitis C virus infection: evidence for an association with type 2 diabetes

21 January 2018

1 reference

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

21 January 2018

1 reference

Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis

21 January 2018

1 reference

Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt

21 January 2018

1 reference

Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients

21 January 2018

1 reference

Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status

21 January 2018

1 reference

Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality

21 January 2018

1 reference

New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection.

21 January 2018

1 reference

Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation

21 January 2018

1 reference

Review article: hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation

21 January 2018

1 reference

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection

21 January 2018

1 reference

Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy

21 January 2018

1 reference

A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.

21 January 2018

1 reference

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

21 January 2018

1 reference

Steatosis affects chronic hepatitis C progression in a genotype specific way

21 January 2018

1 reference

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

21 January 2018

1 reference

Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis

21 January 2018

1 reference

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study

21 January 2018

1 reference

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.

21 January 2018

1 reference

Prognostic significance of glycaemic control in patients with HBV and HCV-related cirrhosis and diabetes mellitus

21 January 2018

1 reference

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

21 January 2018

1 reference

HCV and diabetes. A two-question-based reappraisal

21 January 2018

1 reference

Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

21 January 2018

1 reference

Histopathology of hepatitis C virus infection

21 January 2018

1 reference

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

21 January 2018

1 reference

Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic

21 January 2018

1 reference

Hepatitis C Viremia Increases the Association With Type 2 Diabetes Mellitus in a Hepatitis B and C Endemic Area: An Epidemiological Link With Virological Implication

21 January 2018

1 reference

Persistent hyperendemicity of hepatitis C virus infection in Taiwan: The important role of iatrogenic risk factors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERI.09.3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19344243%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference